Oxford Handbook of the Economics of the Biopharmaceutical Industry
Wydanie: 2012 r.
Dostępność: aktualnie niedostępny
This timely volume comprises eighteen chapters by leading academics on the economics of the biopharmaceutical industry. Part one examines economic determinants of biopharmaceutical R&D including financing, regulation, and patents. Part two addresses major issues in pharmaceutical markets including pricing, price regulation, and promotion; insurance coverage and effects of patient cost-sharing; the health value of pharmaceuticals; and the endemic use of mergers, acquisitions, and alliances.